  See all
 |
Articles: Chemotherapy/Oncology |
Prior Articles
Apoptosis induction effects of EGCG in laryngeal squamous cell carcinoma cells through telomerase repression
Archives of Pharmacal Research, 10/12/09
Free full text
Targeting of HDAC8 and investigational inhibitors in neuroblastoma
Expert Opinion on Investigational Drugs, 10/09/09 Imatinib: a study in the quality of adverse events reporting
Community Oncology, 10/09/09
Free full text
Justification of the starting dose as the main determinant of accrual time in dose-seeking oncology phase 1 trials
Investigational New Drugs, 10/08/09 A phase-II trial of dose-dense chemotherapy in patients with disseminated thymoma: report of a Japan Clinical Oncology Group trial (JCOG 9605)
British Journal of Cancer, 10/08/09 Lovastatin overcomes gefitinib resistance in human non-small cell lung cancer cells with K-Ras mutations
Investigational New Drugs, 10/08/09 Phase I clinical and pharmacokinetic study of sorafenib in combination with carboplatin and paclitaxel in patients with advanced non–small cell lung cancer
Investigational New Drugs, 10/08/09 Phase I/II study of sunitinib malate in Japanese patients with gastrointestinal stromal tumor after failure of prior treatment with imatinib mesylate
Investigational New Drugs, 10/08/09
Free full text
Arsthinol nanosuspensions: pharmacokinetics and anti-leukaemic activity on NB4 promyelocytic leukaemia cells
Journal of Pharmacy and Pharmacology, 10/07/09 Caffeine-potentiated chemotherapy for metastatic osteosarcoma
Journal of Orthopaedic Science, 10/06/09 AVE8062: a new combretastatin derivative vascular disrupting agent
Expert Opinion on Investigational Drugs, 10/06/09 Induction of apoptosis and cell cycle arrest in human HCC MHCC97H cells with Chrysanthemum indicum extract
World Journal of Gastroenterology, 10/06/09
Free full text
Is zoledronic acid an anticancer drug
Expert Opinion in Pharmacotherapy, 10/05/09 A review on the treatment of relapsed/metastatic head and neck cancer
Expert Opinion in Pharmacotherapy, 10/05/09 Oxaliplatin induces apoptosis in hepatocellular carcinoma cells and inhibits tumor growth
Expert Opinion on Investigational Drugs, 10/02/09 Current data of targeted therapies for the treatment of triple-negative advanced breast cancer: empiricism or evidence-based
Expert Opinion on Investigational Drugs, 10/02/09
Exclusive Author Commentary A dose-finding and pharmacodynamic study of bortezomib in combination with weekly paclitaxel in patients with advanced solid tumors
Cancer Chemotherapy and Pharmacology, 10/01/09
Exclusive Author Commentary A Comparison of Phase II Study Strategies
Clinical Cancer Research, 10/01/09 Phase I Dose-Escalation and Pharmacokinetic Study of Dasatinib in Patients with Advanced Solid Tumors
Clinical Cancer Research, 10/01/09 Chemotherapy-induced neutropenia as a prognostic factor in advanced non-small-cell lung cancer: results from Japan Multinational Trial Organization LC00-03
British Journal of Cancer, 10/01/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
250 Available Pages
|
|
